Dr William Stevenson

MBBS,BSc(Med),PhD,FRACP,FRCPA
Clinical Associate Professor
Medicine, Northern Clinical School

Telephone +61 2 9926 7111
Fax +61 2 9906 4070

Map

Selected grants

2012

  • Development of Genome Editing for the precise modification of Human cell Lines; Stevenson W; Northern Sydney Local Health District/Research Support.

2011

  • Translational health services research grant-improving psychosocial outcomes for haematological cancer patients; Sanson-Fisher R, Stevenson W; Cancer Institute New South Wales/Translational Health Services Research Grant.

2007

  • Cancer Institute of NSW - International Clinical and Research Fellowship; Stevenson W; Cancer Institute New South Wales/International and Clinical Research Fellowship.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Gifford, G., Wong, K., Kerridge, I., Stevenson, W., Arthur, C., Fay, K., Greenwood, M. (2015). Addition of low dose total body irradiation to fludarabine melphalan reduced intensity conditioning is feasible, tolerable, and may improve outcomes in patients with high-risk acute myeloid leukaemia and other high risk myeloid malignancies. American Journal Of Hematology, 90(5), e97-e100. [More Information]
  • Lynagh, M., Clinton-Mcharg, T., Hall, A., Sanson-Fisher, R., Stevenson, W., Tiley, C., Bisquera, A. (2015). Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studies. Experimental Hematology & Oncology, 4, 1-8. [More Information]
  • Wei, A., Tan, P., Perruzza, S., Govindaraj, C., Fleming, S., Macmanus, J., Avery, S., Patil, S., Stevenson, W., Plebanski, M., et al (2015). Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia. British Journal of Haematology, 169(2), 199-210. [More Information]
  • Stevenson, W., Rabbolini, D., Beutler, L., Chen, Q., Gabrielli, S., Mackay, J., Brighton, T., Ward, C., Morel-Kopp, M. (2015). Paris-Trousseau thrombocytopenia is phenocopied by the autosomal recessive inheritance of a DNA-binding domain mutation in FLI1. Blood, 126(17), 2027-2030. [More Information]
  • Stevenson, W., Morel-Kopp, M., Ward, C. (2015). Platelets are not all gray in GFI1B disease. Clinical Genetics, 87(3), 299-299. [More Information]
  • Ho, J., Marlton, P., Tam, C., Stevenson, W., Ritchie, D., Bird, R., Dunlop, L., Durrant, S., Ross, D. (2015). Practical management of myelofibrosis with ruxolitinib. Internal Medicine Journal, 45(12), 1221-1230. [More Information]
  • Bryant, J., Sanson-Fisher, R., Stevenson, W., Smits, R., Henskens, F., Wei, A., Tzelepis, F., D'Este, C., Paul, C., Carey, M. (2015). Protocol of a multi-centre randomised controlled trial of a web-based information intervention with nurse-delivered telephone support for haematological cancer patients and their support persons. BMC Cancer, 15(1), 1-13. [More Information]
  • Estecio, M., Madipoti, S., Bueso-Ramos, C., DiNardo, C., Yang, H., Wei, Y., Kondo, K., Fang, Z., Stevenson, W., Chang, K., et al (2015). RUNX3 promoter hypermethylation is frequent in leukaemia cell lines and associated with acute myeloid leukaemia inv(16) subtype. British Journal of Haematology, 169(3), 344-351. [More Information]
  • Crassini, K., Stevenson, W., Mulligan, S., Best, O. (2015). The MEK1/2 inhibitor, MEKi-1, induces cell death in chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment and is synergistic with fludarabine. Leukemia & Lymphoma, 56(12), 3407-3417. [More Information]
  • Stevenson, W., Best, O., Przybylla, A., Chen, Q., Singh, N., Koleth, M., Pierce, S., Kennedy, T., Tong, W., Kuang, S., et al (2014). DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukemia. Leukemia, 28(4), 787-793. [More Information]
  • Rabbolini, D., Morel-Kopp, M., Stevenson, W., Ward, C. (2014). Inherited Macrothrombocytopenias. Seminars in Thrombosis and Hemostasis, 40(7), 774-784. [More Information]
  • Smits, R., Bryant, J., Sanson-Fisher, R., Tzelepis, F., Henskens, F., Paul, C., Stevenson, W. (2014). Tailored and Integrated Web-Based Tools for Improving Psychosocial Outcomes of Cancer Patients: The DoTTI Development Framework. Journal of Medical Internet Research, 16(3), 1-17. [More Information]
  • Stevenson, W., Morel-Kopp, M., Chen, Q., Liang, H., Bromhead, C., Wright, S., Turakulov, R., Ng, A., Roberts, A., Bahlo, M., Ward, C. (2013). GFI1B mutation causes a bleeding disorder with abnormal platelet function. Journal of Thrombosis and Haemostasis, 11(11), 2039-2047. [More Information]
  • Freeman, J., Crassini, K., Best, G., Forsyth, C., MacKinlay, N., Han, P., Stevenson, W., Mulligan, S. (2013). Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia. Leukemia & Lymphoma, 54(1), 99-104. [More Information]
  • Singh, N., Morris, C., Koleth, M., Wong, K., Ward, C., Stevenson, W. (2013). Polyploidy in myelofibrosis: analysis by cytogenetic and SNP array indicates association with advancing disease. Molecular Cytogenetics, 6(1), 1-12. [More Information]
  • Hain, S., Khan, S., Stevenson, W. (2012). 18F-FDG PET to identify soft tissue disease in multiple myeloma. European Journal of Nuclear Medicine and Molecular Imaging, 39(3), 553-554. [More Information]
  • Dayyani, F., Conley, A., Strom, S., Stevenson, W., Cortes, J., Borthakur, G., Faderl, S., O'Brien, S., Pierce, S., Kantarjian, H., et al (2010). Cause of death in patients with lower-risk myelodysplastic syndrome. Cancer, 116(9), 2174-2179. [More Information]
  • Stevenson, W., Hyland, C., Zhang, J., Morgan, P., Wilson, T., Gill, A., Hilton, A., Viney, E., Bahlo, M., Masters, S., et al (2010). Deficiency of 5-hydroxyisourate hydrolase causes hepatomegaly and hepatocellular carcinoma in mice. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 107(38), 16625-16630. [More Information]
  • Tong, W., Wei, Y., Stevenson, W., Kuang, S., Fang, Z., Zhang, M., Arts, J., Garcia-Manero, G. (2010). Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor. Leukemia Research: clinical and laboratory studies, 34(2), 221-228. [More Information]
  • Stevenson, W., Nankivell (Nankievell), B., Hertzberg, M. (2005). Nephrotic syndrome after stem cell transplantation. Clinical Transplantation, 19(1), 141-144. [More Information]

2015

  • Gifford, G., Wong, K., Kerridge, I., Stevenson, W., Arthur, C., Fay, K., Greenwood, M. (2015). Addition of low dose total body irradiation to fludarabine melphalan reduced intensity conditioning is feasible, tolerable, and may improve outcomes in patients with high-risk acute myeloid leukaemia and other high risk myeloid malignancies. American Journal Of Hematology, 90(5), e97-e100. [More Information]
  • Lynagh, M., Clinton-Mcharg, T., Hall, A., Sanson-Fisher, R., Stevenson, W., Tiley, C., Bisquera, A. (2015). Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studies. Experimental Hematology & Oncology, 4, 1-8. [More Information]
  • Wei, A., Tan, P., Perruzza, S., Govindaraj, C., Fleming, S., Macmanus, J., Avery, S., Patil, S., Stevenson, W., Plebanski, M., et al (2015). Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia. British Journal of Haematology, 169(2), 199-210. [More Information]
  • Stevenson, W., Rabbolini, D., Beutler, L., Chen, Q., Gabrielli, S., Mackay, J., Brighton, T., Ward, C., Morel-Kopp, M. (2015). Paris-Trousseau thrombocytopenia is phenocopied by the autosomal recessive inheritance of a DNA-binding domain mutation in FLI1. Blood, 126(17), 2027-2030. [More Information]
  • Stevenson, W., Morel-Kopp, M., Ward, C. (2015). Platelets are not all gray in GFI1B disease. Clinical Genetics, 87(3), 299-299. [More Information]
  • Ho, J., Marlton, P., Tam, C., Stevenson, W., Ritchie, D., Bird, R., Dunlop, L., Durrant, S., Ross, D. (2015). Practical management of myelofibrosis with ruxolitinib. Internal Medicine Journal, 45(12), 1221-1230. [More Information]
  • Bryant, J., Sanson-Fisher, R., Stevenson, W., Smits, R., Henskens, F., Wei, A., Tzelepis, F., D'Este, C., Paul, C., Carey, M. (2015). Protocol of a multi-centre randomised controlled trial of a web-based information intervention with nurse-delivered telephone support for haematological cancer patients and their support persons. BMC Cancer, 15(1), 1-13. [More Information]
  • Estecio, M., Madipoti, S., Bueso-Ramos, C., DiNardo, C., Yang, H., Wei, Y., Kondo, K., Fang, Z., Stevenson, W., Chang, K., et al (2015). RUNX3 promoter hypermethylation is frequent in leukaemia cell lines and associated with acute myeloid leukaemia inv(16) subtype. British Journal of Haematology, 169(3), 344-351. [More Information]
  • Crassini, K., Stevenson, W., Mulligan, S., Best, O. (2015). The MEK1/2 inhibitor, MEKi-1, induces cell death in chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment and is synergistic with fludarabine. Leukemia & Lymphoma, 56(12), 3407-3417. [More Information]

2014

  • Stevenson, W., Best, O., Przybylla, A., Chen, Q., Singh, N., Koleth, M., Pierce, S., Kennedy, T., Tong, W., Kuang, S., et al (2014). DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukemia. Leukemia, 28(4), 787-793. [More Information]
  • Rabbolini, D., Morel-Kopp, M., Stevenson, W., Ward, C. (2014). Inherited Macrothrombocytopenias. Seminars in Thrombosis and Hemostasis, 40(7), 774-784. [More Information]
  • Smits, R., Bryant, J., Sanson-Fisher, R., Tzelepis, F., Henskens, F., Paul, C., Stevenson, W. (2014). Tailored and Integrated Web-Based Tools for Improving Psychosocial Outcomes of Cancer Patients: The DoTTI Development Framework. Journal of Medical Internet Research, 16(3), 1-17. [More Information]

2013

  • Stevenson, W., Morel-Kopp, M., Chen, Q., Liang, H., Bromhead, C., Wright, S., Turakulov, R., Ng, A., Roberts, A., Bahlo, M., Ward, C. (2013). GFI1B mutation causes a bleeding disorder with abnormal platelet function. Journal of Thrombosis and Haemostasis, 11(11), 2039-2047. [More Information]
  • Freeman, J., Crassini, K., Best, G., Forsyth, C., MacKinlay, N., Han, P., Stevenson, W., Mulligan, S. (2013). Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia. Leukemia & Lymphoma, 54(1), 99-104. [More Information]
  • Singh, N., Morris, C., Koleth, M., Wong, K., Ward, C., Stevenson, W. (2013). Polyploidy in myelofibrosis: analysis by cytogenetic and SNP array indicates association with advancing disease. Molecular Cytogenetics, 6(1), 1-12. [More Information]

2012

  • Hain, S., Khan, S., Stevenson, W. (2012). 18F-FDG PET to identify soft tissue disease in multiple myeloma. European Journal of Nuclear Medicine and Molecular Imaging, 39(3), 553-554. [More Information]

2010

  • Dayyani, F., Conley, A., Strom, S., Stevenson, W., Cortes, J., Borthakur, G., Faderl, S., O'Brien, S., Pierce, S., Kantarjian, H., et al (2010). Cause of death in patients with lower-risk myelodysplastic syndrome. Cancer, 116(9), 2174-2179. [More Information]
  • Stevenson, W., Hyland, C., Zhang, J., Morgan, P., Wilson, T., Gill, A., Hilton, A., Viney, E., Bahlo, M., Masters, S., et al (2010). Deficiency of 5-hydroxyisourate hydrolase causes hepatomegaly and hepatocellular carcinoma in mice. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 107(38), 16625-16630. [More Information]
  • Tong, W., Wei, Y., Stevenson, W., Kuang, S., Fang, Z., Zhang, M., Arts, J., Garcia-Manero, G. (2010). Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor. Leukemia Research: clinical and laboratory studies, 34(2), 221-228. [More Information]

2005

  • Stevenson, W., Nankivell (Nankievell), B., Hertzberg, M. (2005). Nephrotic syndrome after stem cell transplantation. Clinical Transplantation, 19(1), 141-144. [More Information]

To update your profile click here. For support on your academic profile contact .